Gregory M. Vercellotti - Publications

Affiliations: 
Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Medicine and Surgery, Molecular Biology, Animal Physiology Biology

172 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ivy ZK, Belcher JD, Khasabova IA, Chen C, Juliette JP, Abdulla FR, Ruan C, Allen K, Nguyen J, Rogness VM, Beckman JD, Khasabov SG, Gupta K, Taylor RP, Simone DA, ... Vercellotti GM, et al. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation. Blood. PMID 37774369 DOI: 10.1182/blood.2022019282  0.687
2023 Belcher JD, Nataraja S, Abdulla F, Zhang P, Chen C, Nguyen J, Ruan C, Singh M, Demes S, Olson L, Stickens D, Stanwix J, Clarke E, Huang Y, Biddle M, ... Vercellotti GM, et al. The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease. Frontiers in Medicine. 10: 1101501. PMID 37144034 DOI: 10.3389/fmed.2023.1101501  0.343
2023 Beckman JD, DaSilva A, Aronovich E, Nguyen A, Nguyen J, Hargis G, Reynolds D, Vercellotti GM, Betts B, Wood DK. JAK-STAT inhibition reduces endothelial pro-thrombotic activation and leukocyte- endothelial pro-adhesive interactions. Journal of Thrombosis and Haemostasis : Jth. PMID 36738826 DOI: 10.1016/j.jtha.2023.01.027  0.667
2023 Sparkenbaugh EM, Henderson MW, Miller-Awe MD, Abrams C, Ilich A, Trebak F, Ramadas N, Vital SA, Bohinc D, Bane K, Chen C, Patel M, Wallisch M, Renné T, Gruber A, ... ... Vercellotti GM, et al. Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood. PMID 36706361 DOI: 10.1182/blood.2022017074  0.311
2023 An R, Man Y, Cheng K, Zhang T, Chen C, Wang F, Abdulla F, Kucukal E, Wulftange WJ, Goreke U, Bode A, Nayak LV, Vercellotti GM, Belcher JD, Little JA, et al. Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor. British Journal of Haematology. PMID 36604837 DOI: 10.1111/bjh.18616  0.324
2022 Belcher JD, Nguyen J, Chen C, Abdulla F, Conglin R, Ivy ZK, Cummings J, Dudler T, Vercellotti GM. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 35878790 DOI: 10.1016/j.trsl.2022.06.018  0.334
2022 Gentinetta T, Belcher JD, Brügger-Verdon V, Adam J, Ruthsatz T, Bain J, Schu D, Ventrici L, Edler M, Lioe H, Patel K, Chen C, Nguyen J, Abdulla F, Zhang P, ... ... Vercellotti GM, et al. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence. Journal of Clinical Medicine. 11. PMID 35160081 DOI: 10.3390/jcm11030630  0.337
2021 El Jurdi N, Elhusseini H, Beckman J, DeFor TE, Okoev G, Rogosheske J, Lazaryan A, Weiler K, Bachanova V, Betts BC, Blazar BR, Brunstein CG, He F, Holtan SG, Janakiram M, ... ... Vercellotti G, et al. High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group. Blood Cancer Journal. 11: 96. PMID 34006823 DOI: 10.1038/s41408-021-00488-2  0.647
2021 Zhang P, Nguyen J, Abdulla F, Nelson AT, Beckman JD, Vercellotti GM, Belcher JD. Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells. Frontiers in Immunology. 12: 632709. PMID 33841413 DOI: 10.3389/fimmu.2021.632709  0.679
2020 Beckman JD, Abdullah F, Chen C, Kirchner R, Rivera-Rodriguez D, Kiser ZM, Nguyen A, Zhang P, Nguyen J, Hebbel RP, Belcher JD, Vercellotti GM. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease. Frontiers in Immunology. 11: 613278. PMID 33542720 DOI: 10.3389/fimmu.2020.613278  0.723
2020 Belcher JD, Zhang P, Nguyen J, Kiser ZM, Nath KA, Hu J, Trent JO, Vercellotti GM. Identification of a Heme Activation Site on the MD-2/TLR4 Complex. Frontiers in Immunology. 11: 1370. PMID 32695117 DOI: 10.1182/Blood-2019-123788  0.312
2020 Holtan SG, Hoeschen AL, Cao Q, Arora M, Bachanova V, Brunstein CG, Miller JS, Rashidi A, Slungaard A, Ustun C, Vercellotti GM, Warlick ED, Betts BC, El Jurdi N, He F, et al. Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor. Blood Advances. 4: 1284-1295. PMID 32236525 DOI: 10.1182/Bloodadvances.2019001259  0.318
2020 Hebbel RP, Belcher JD, Vercellotti GM. The multifaceted role of ischemia/reperfusion in sickle cell anemia. The Journal of Clinical Investigation. 130: 1062-1072. PMID 32118586 DOI: 10.1172/Jci133639  0.316
2020 Nath KA, Grande JP, Belcher JD, Garovic VD, Croatt AJ, Hillestad ML, Barry MA, Nath MC, Regan RF, Vercellotti GM. Antithrombotic Effects of Heme-Degrading and Heme-Binding Proteins. American Journal of Physiology. Heart and Circulatory Physiology. PMID 32004074 DOI: 10.1152/Ajpheart.00280.2019  0.374
2020 Sparkenbaugh EM, Chen C, Brzoska T, Nguyen J, Wang S, Vercellotti GM, Key NS, Sundd P, Belcher JD, Pawlinski R. Thrombin-mediated activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease. Blood. PMID 31977004 DOI: 10.1182/Blood.2019003543  0.438
2019 Kiser ZM, Lizcano A, Nguyen J, Becker GL, Belcher JD, Varki AP, Vercellotti GM. Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease. Blood Cells, Molecules & Diseases. 81: 102399. PMID 31901888 DOI: 10.1016/J.Bcmd.2019.102399  0.351
2019 Nath KA, Garovic VD, Grande JP, Croatt AJ, Ackerman AW, Farrugia G, Katusic ZS, Belcher JD, Vercellotti GM. Heme Oxygenase-2 Protects Against Ischemic Acute Kidney Injury: The Influence of Age and Sex. American Journal of Physiology. Renal Physiology. PMID 31215802 DOI: 10.1152/Ajprenal.00085.2019  0.364
2019 McArthur JG, Svenstrup N, Chen C, Fricot A, Carvalho C, Nguyen J, Nguyen P, Prachikova A, Abdulla F, Vercellotti GM, Hermine O, Edwards D, Ribeil JA, Belcher JD, Maciel TT. A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease. Haematologica. PMID 31147439 DOI: 10.3324/Haematol.2018.213462  0.39
2019 Belcher JD, Biddle M, Stickens D, Olson L, Bell E, Chen C, Abdulla F, Nguyen J, Kiser ZM, Lloyd J, Vercellotti GM. Bach1 Inhibitors Reduce Stasis in Townes Sickle Cell Mouse Model Blood. 134: 983-983. DOI: 10.1182/Blood-2019-127300  0.421
2019 Belcher JD, Abdulla F, Chen C, Zhang P, Rivera-Rodriguez D, Kirchner R, Nguyen J, Kiser ZM, Nachbor K, Lloyd J, Vercellotti GM. Deletion of TLR4 in Townes SS Mice Prevents Microvascular Stasis in Response to Hemin, LPS and Hypoxia/Reoxygenation: Role of Inflammation Blood. 134: 3555-3555. DOI: 10.1182/Blood-2019-127114  0.342
2019 Zhang P, Belcher JD, Nguyen J, Abdulla F, Vercellotti GM. Increased Release of Soluble MD-2 in Sickle Cell Disease and Its Role in Pro-Inflammatory Signaling in Endothelial Cells Blood. 134: 208-208. DOI: 10.1182/Blood-2019-122912  0.365
2018 Vercellotti GM, Dalmasso AP, Schaid TR, Nguyen J, Chen C, Ericson ME, Abdulla F, Killeen T, Lindorfer MA, Taylor RP, Belcher JD. Critical role of C5a in sickle cell disease. American Journal of Hematology. PMID 30569594 DOI: 10.1002/Ajh.25384  0.41
2018 Telen MJ, Malik P, Vercellotti GM. Therapeutic strategies for sickle cell disease: towards a multi-agent approach. Nature Reviews. Drug Discovery. PMID 30514970 DOI: 10.1038/S41573-018-0003-2  0.31
2018 Jana S, Strader MB, Meng F, Hicks W, Kassa T, Tarandovskiy I, De Paoli S, Simak J, Heaven MR, Belcher JD, Vercellotti GM, Alayash AI. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles. Jci Insight. 3. PMID 30385713 DOI: 10.1172/Jci.Insight.120451  0.394
2018 Belcher JD, Gomperts E, Nguyen J, Chen C, Abdulla F, Kiser ZM, Gallo D, Levy H, Otterbein LE, Vercellotti GM. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia. Plos One. 13: e0205194. PMID 30308028 DOI: 10.1371/Journal.Pone.0205194  0.423
2018 Belcher JD, Chen C, Nguyen J, Abdulla F, Zhang P, Nguyen H, Nguyen P, Killeen T, Miescher SM, Brinkman N, Nath KA, Steer CJ, Vercellotti GM. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction. Plos One. 13: e0196455. PMID 29694434 DOI: 10.1371/Journal.Pone.0196455  0.492
2018 Sparkenbaugh E, Chen C, Nguyen J, Wang S, Vercellotti GM, Belcher JD, Pawlinski R. Thrombin-mediated activation of par-1 contributes to microvascular stasis in mouse models of sickle cell disease via increased endothelial expression of p-selectin and vwf Blood. 132: 266-266. DOI: 10.1182/Blood-2018-99-116238  0.4
2018 Kiser ZM, Becker GL, Nguyen J, Lizcano A, Belcher JD, Varki AP, Vercellotti GM. Decreased Erythrocyte Binding Capability for Neutrophil Siglec-9 Is a Source of Oxidative Stress in Sickle Cell Disease Blood. 132: 3650-3650. DOI: 10.1182/Blood-2018-99-113579  0.327
2017 Louie JE, Anderson CJ, Fayaz M Fomani K, Henry A, Killeen T, Mohandas N, Yazdanbakhsh K, Belcher JD, Vercellotti GM, Shi PA. Case series supporting heme detoxification via therapeutic plasma exchange in acute multiorgan failure syndrome resistant to red blood cell exchange in sickle cell disease. Transfusion. PMID 29193101 DOI: 10.1111/Trf.14407  0.331
2017 Turcotte LM, DeFor TE, Newell LF, Cutler CS, Verneris MR, Wu J, Howard A, MacMillan ML, Antin JH, Vercellotti GM, Slungaard A, Blazar BR, Weisdorf DJ, Panoskaltsis-Mortari A, Holtan SG. Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402. Bone Marrow Transplantation. PMID 29058696 DOI: 10.1038/Bmt.2017.236  0.303
2017 Nath KA, Belcher JD, Nath MC, Grande JP, Croatt AJ, Ackerman AW, Katusic ZS, Vercellotti GM. The Role of TLR4 Signaling in the Nephrotoxicity of Heme and Heme Proteins. American Journal of Physiology. Renal Physiology. ajprenal.00432.2017. PMID 28978536 DOI: 10.1152/Ajprenal.00432.2017  0.36
2017 Solovey A, Somani A, Belcher JD, Milbauer L, Vincent L, Pawlinski R, Nath KA, Kelm RJ, Mackman N, O'Sullivan MG, Gupta K, Vercellotti GM, Hebbel RP. A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade. American Journal of Hematology. PMID 28699284 DOI: 10.1002/Ajh.24856  0.421
2017 Gomperts E, Belcher JD, Otterbein L, Coates T, Wood J, Skolnick BE, Levy H, Vercellotti GM. The Role of Carbon Monoxide and Heme Oxygenase in the Prevention of Sickle Cell Disease Vaso-Occlusive Crises. American Journal of Hematology. PMID 28378932 DOI: 10.1002/Ajh.24750  0.369
2016 Shi PA, Choi E, Chintagari NR, Nguyen J, Guo X, Yazdanbakhsh K, Mohandas N, Alayash AI, Manci EA, Belcher JD, Vercellotti GM. Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function. British Journal of Haematology. PMID 27507623 DOI: 10.1111/Bjh.14280  0.389
2016 Vercellotti GM, Zhang P, Nguyen J, Abdulla F, Chen C, Nguyen P, Nowotny C, Steer CJ, Smith A, Belcher JD. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease. Molecular Medicine (Cambridge, Mass.). 22. PMID 27451971 DOI: 10.2119/Molmed.2016.00063  0.46
2016 Belcher JD, Chen C, Nguyen J, Zhang P, Abdulla F, Nguyen P, Killeen T, Xu P, O'Sullivan G, Nath K, Vercellotti G. Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate. Antioxidants & Redox Signaling. PMID 26914345 DOI: 10.1089/Ars.2015.6571  0.37
2016 Jana S, Strader MB, Kassa T, Meng F, Hicks W, Tarandovskiy I, De Paoli S, Simak J, Miller JL, Mendelsohn L, Nichols J, Thein SL, Belcher JD, Vercellotti GM, Alayash A. Hemoglobin S Oxidation Promotes Plasma-Derived Microparticle Membrane Alterations and Toxicity Blood. 128: 856-856. DOI: 10.1182/Blood.V128.22.856.856  0.424
2016 Santiago RP, Guarda CC, Figueiredo CVB, Fiuza LM, Adanho CSA, Aleluia MM, Zanette DL, Carvalho MOS, Lyra IM, Lopes VM, Nguyen J, Killeen T, Nguyen H, Vercellotti GM, Belcher JD, et al. Serum Haptoglobin and Hemopexin Levels in Pediatric SS and SC Disease Patients: Biomarker of Hemolysis and Inflammation Blood. 128: 3649-3649. DOI: 10.1182/Blood.V128.22.3649.3649  0.339
2016 McArthur JG, Maciel T, Chen C, Fricot A, Kobayashi D, Nguyen J, Nguyen P, Parachova A, Abdulla F, Vercellotti GM, Svenstrup N, Belcher JD. A Novel, Highly Potent and Selective PDE9 Inhibitor for the Treatment of Sickle Cell Disease Blood. 128: 268-268. DOI: 10.1182/Blood.V128.22.268.268  0.386
2016 Belcher JD, Chen C, Nguyen J, Abdulla F, Nguyen P, Nguyen H, Zhang P, Brinkman N, Vercellotti GM. Haptoglobin and Hemopexin Infusion Efficiently Activates the Nrf2/HO-1 Axis and Inhibits Inflammation and Vaso-Occlusion in Murine Sickle Cell Disease Blood. 128: 2477-2477. DOI: 10.1182/Blood.V128.22.2477.2477  0.448
2016 Vinchi F, Vercellotti GM, Belcher JD, Fibach E, Zreid H, Rasras R, Ghoti H, Muckenthaler MU, Rachmilewitz EA. Systemic Heme and Iron Overload Results in Depletion of Serum Hemopexin, Haptoglobin and Transferrin and Correlates with Markers of Endothelial Activation and Lipid Oxidation in Beta Thalassemia Major and Intermedia Blood. 128: 2469-2469. DOI: 10.1182/Blood.V128.22.2469.2469  0.36
2016 Schaid TR, Nguyen J, Chen C, Abdulla F, Killeen T, Nguyen H, Edmund J, Lindorfer MA, Taylor RP, Dalmasso AP, Belcher JD, Vercellotti GM. Complement Activation in a Murine Model of Sickle Cell Disease: Inhibition of Vaso-Occlusion By Blocking C5 Activation Blood. 128: 158-158. DOI: 10.1182/Blood.V128.22.158.158  0.39
2015 Vercellotti GM. Special delivery: microparticles convey heme. Blood. 125: 3677-8. PMID 26069333 DOI: 10.1182/Blood-2015-04-639484  0.348
2015 Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Blazar BR, Panoskaltsis-Mortari A, Weisdorf DJ. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1029-36. PMID 25759146 DOI: 10.1016/J.Bbmt.2015.02.018  0.328
2015 Belcher JD, Chen C, Nguyen J, Abdulla F, Nguyen P, Nguyen M, Okeley NM, Benjamin DR, Senter PD, Vercellotti GM. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice. Plos One. 10: e0117772. PMID 25706118 DOI: 10.1371/Journal.Pone.0117772  0.459
2015 Chintagari NR, Nguyen J, Belcher JD, Vercellotti GM, Alayash AI. Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease. Blood Cells, Molecules & Diseases. 54: 302-6. PMID 25582460 DOI: 10.1016/J.Bcmd.2014.12.001  0.394
2015 Vercellotti GM, Zhang P, Chen C, Nguyen J, Abdulla F, Nguyen P, Nowotny C, Irfanullah A, Smith A, Steer CJ, Belcher JD. Hemopexin Gene Therapy Inhibits Inflammation and Vaso-Occlusion in Transgenic Sickle Cell Mice Blood. 126: 412-412. DOI: 10.1182/Blood.V126.23.412.412  0.451
2015 Cataldo G, Lunzer MM, Simone DA, Akgün E, Belcher JD, Vercellotti GM, Portoghese PS. Targeting Putative Mu Opioid/Chemokine Receptor Type 5 Heteromers Potently Attenuates Nociception in a Murine Model of Sickle Cell Disease Blood. 126: 277-277. DOI: 10.1182/Blood.V126.23.277.277  0.366
2015 Shi PA, Choi E, Nguyen J, Guo X, Mohandas N, Alayash A, Manci E, Belcher JD, Vercellotti GM. Three Months of Human Haptoglobin Treatment Decreases Iron Deposition in the Kidneys of Townes Sickle Mice Blood. 126: 2163-2163. DOI: 10.1182/Blood.V126.23.2163.2163  0.4
2014 Vercellotti GM. Look out heme, Mac is back in town. Blood. 124: 1388-9. PMID 25170114 DOI: 10.1182/Blood-2014-07-585950  0.343
2014 Vercellotti GM, Khan FB, Nguyen J, Chen C, Bruzzone CM, Bechtel H, Brown G, Nath KA, Steer CJ, Hebbel RP, Belcher JD. H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice. Frontiers in Pharmacology. 5: 79. PMID 24860503 DOI: 10.3389/Fphar.2014.00079  0.452
2014 Khan F, Linden MA, Zantek ND, Vercellotti GM. Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation Transfusion Medicine. 24: 187-188. PMID 24809981 DOI: 10.1111/Tme.12121  0.358
2014 Vercellotti GM, Belcher JD. Not simply misshapen red cells: multimolecular and cellular events in sickle vaso-occlusion. The Journal of Clinical Investigation. 124: 1462-5. PMID 24642460 DOI: 10.1172/Jci75238  0.386
2014 Belcher JD, Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI, Smith A, Nath KA, Hebbel RP, Vercellotti GM. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 123: 377-90. PMID 24277079 DOI: 10.1182/Blood-2013-04-495887  0.419
2014 Belcher JD, Nguyen J, Chen C, Abdulla F, Nguyen P, Nguyen M, Zhang P, Xu P, Slipek NJ, Vercellotti GM. Dimethyl Fumarate Induces Cytoprotection and Inhibits Inflammation and Vaso-Occlusion in Transgenic Sickle Mice Blood. 124: 219-219. DOI: 10.1182/Blood.V124.21.219.219  0.47
2013 Belcher JD, Nath KA, Vercellotti GM. Vasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses. Isrn Oxidative Medicine. 2013. PMID 25506596 DOI: 10.1155/2013/831596  0.361
2013 Sjeklocha LM, Wong PY, Belcher JD, Vercellotti GM, Steer CJ. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model. Plos One. 8: e80403. PMID 24260386 DOI: 10.1371/Journal.Pone.0080403  0.333
2013 Wegiel B, Gallo D, Csizmadia E, Harris C, Belcher J, Vercellotti GM, Penacho N, Seth P, Sukhatme V, Ahmed A, Pandolfi PP, Helczynski L, Bjartell A, Persson JL, Otterbein LE. Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Research. 73: 7009-21. PMID 24121491 DOI: 10.1158/0008-5472.Can-13-1075  0.305
2013 Belcher JD, Young M, Chen C, Nguyen J, Burhop K, Tran P, Vercellotti GM. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice. Blood. 122: 2757-64. PMID 23908468 DOI: 10.1182/Blood-2013-02-486282  0.428
2013 Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 121: 1276-84. PMID 23264591 DOI: 10.1182/Blood-2012-11-451229  0.373
2013 Nath KA, Grande JP, Farrugia G, Croatt AJ, Belcher JD, Hebbel RP, Vercellotti GM, Katusic ZS. Age sensitizes the kidney to heme protein-induced acute kidney injury. American Journal of Physiology. Renal Physiology. 304: F317-25. PMID 23195679 DOI: 10.1152/Ajprenal.00606.2012  0.38
2013 Belcher JD, Chen C, Nguyen J, Okeley NM, Senter PD, Benjamin DR, Vercellotti GM. Fucosylation Inhibitor, 2-Fluorofucose, Inhibits NF-κB Activation and Vaso-Occlusion In Transgenic Sickle Mice Blood. 122: 730-730. DOI: 10.1182/Blood.V122.21.730.730  0.425
2013 Solovey A, Somani A, Chen C, Kiley J, Marker P, Abdulla F, O'Sullivan MG, Kelm RJ, Belcher JD, Vercellotti GM, Hebbel RP. Interference With TNFα Using Long-Term Etanercept In S+SAntilles Sickle Transgenic Mice Ameliorates Abnormal Endothelial Activation, Vasoocclusion, and Pulmonary Hypertension Including Its Pulmonary Arterial Wall Remodeling Blood. 122: 728-728. DOI: 10.1182/Blood.V122.21.728.728  0.409
2013 Khan F, Linden MA, Zantek ND, Vercellotti GM. Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation Blood. 122: 5495-5495. DOI: 10.1182/Blood.V122.21.5495.5495  0.355
2013 Mathson K, Teena R, Belcher JD, Vercellotti GM, Slungaard A. Thiocyanate Blocks Peroxidase-Dependent Extracellular Trap (ET) Formation By PMN and Eosinophils: Heme Is a Potent New Agonist For The ET Pathway Blood. 122: 323-323. DOI: 10.1182/Blood.V122.21.323.323  0.333
2013 Rehani T, Mathson K, Belcher JD, Vercellotti GM, Slungaard A. Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases Blood. 122: 2215-2215. DOI: 10.1182/Blood.V122.21.2215.2215  0.387
2013 Ustun C, Reiter A, Scott BL, Nakamura R, Gandhi D, Kreil S, Shanley R, Hogan WJ, Perales M, Shore TB, Baurmann H, Stuart RK, Gruhn B, Doubek M, Hsu JW, ... ... Vercellotti GM, et al. Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis Blood. 122: 2145-2145. DOI: 10.1182/Blood.V122.21.2145.2145  0.314
2012 Vercellotti GM, Moldow CF, Jacob HS. Complement, oxidants, and endothelial injury: how a bedside observation opened a door to vascular biology. The Journal of Clinical Investigation. 122: 3044-5. PMID 23106086 DOI: 10.1172/Jci64953  0.316
2012 Vercellotti GM, Chen C, Bruzzone CM, Bechtel HA, Ngyuen J, Hebbel RP, Steer CJ, Belcher JD. H-Ferritin Ferroxidase Activity Induces Cytoprotective Pathways and Inhibits Microvascular Stasis in Transgenic Sickle Mice Blood. 120: 378-378. DOI: 10.1182/Blood.V120.21.378.378  0.445
2012 Belcher JD, Chen C, Young M, Burhop K, Vercellotti GM. MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide, Inhibits Microvascular Stasis in Transgenic Sickle Mice Through Heme Oxygenase-1. Blood. 120: 2112-2112. DOI: 10.1182/Blood.V120.21.2112.2112  0.43
2011 Sjeklocha LM, Park CW, Wong PY, Roney MJ, Belcher JD, Kaufman DS, Vercellotti GM, Hebbel RP, Steer CJ. Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. Plos One. 6: e29110. PMID 22216176 DOI: 10.1371/Journal.Pone.0029110  0.301
2011 Kang L, Yamada S, Hernandez MC, Croatt AJ, Grande JP, Juncos JP, Vercellotti GM, Hebbel RP, Katusic ZS, Terzic A, Nath KA. Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. American Journal of Physiology. Renal Physiology. 301: F845-51. PMID 21697243 DOI: 10.1152/Ajprenal.00311.2011  0.326
2011 Juncos R, Juncos L, Hebbel RP, Vercellotti GM, Katusic ZS, Nath KA. Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease. Journal of Cardiovascular Pharmacology. 57: 263-6. PMID 21107280 DOI: 10.1097/Fjc.0B013E318204Bb34  0.343
2011 Beckman JD, Chen C, Nguyen J, Thayanithy V, Subramanian S, Steer CJ, Vercellotti GM. Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. The Journal of Biological Chemistry. 286: 3194-202. PMID 21106538 DOI: 10.1074/Jbc.M110.148726  0.641
2011 Belcher JD, Nguyen J, Chen C, Smith A, Alayash AI, Nair SL, Somani A, Hebbel RP, Vercellotti GM. Plasma Hemoglobin and Heme Trigger Weibel Palade Body Exocytosis and Vaso-Occlusion in Transgenic Sickle Mice Blood. 118: 896-896. DOI: 10.1182/Blood.V118.21.896.896  0.473
2011 Belcher JD, Chen C, Young M, Tran P, Vercellotti GM. Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide Blood. 118: 850-850. DOI: 10.1182/Blood.V118.21.850.850  0.421
2011 Beckman JD, Marker PH, Nguyen J, Belcher JD, Croatt AJ, Nath KA, Hebbel RP, Vercellotti GM. Carbon Monoxide Therapy Modulates Hematopoietic Stem Cell Development in Heme-Oxygenase-1 Knockout Mice Blood. 118: 1318-1318. DOI: 10.1182/Blood.V118.21.1318.1318  0.728
2011 Solovey A, Chang LM, Abdulla F, Kollander R, Marker PH, Kelm R, Vercellotti GM, Hebbel RP. The Blood Monocyte - TNF - Endothelial Axis in Activation of Endothelial Tissue Factor in the Transgenic Sickle Mouse: Possible Relevance of Etanercept to Sickle Coagulopathy Blood. 118: 1048-1048. DOI: 10.1182/Blood.V118.21.1048.1048  0.393
2010 Jiang J, Goel R, Schmechel S, Vercellotti G, Forster C, Bischof J. Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system. Cryobiology. 61: 280-8. PMID 20940007 DOI: 10.1016/J.Cryobiol.2010.09.006  0.318
2010 Sheng WS, Hu S, Nettles AR, Lokensgard JR, Vercellotti GM, Rock RB. Hemin inhibits NO production by IL-1β-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation. Journal of Neuroinflammation. 7: 51. PMID 20822529 DOI: 10.1186/1742-2094-7-51  0.34
2010 Nagy E, Eaton JW, Jeney V, Soares MP, Varga Z, Galajda Z, Szentmiklósi J, Méhes G, Csonka T, Smith A, Vercellotti GM, Balla G, Balla J. Red cells, hemoglobin, heme, iron, and atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1347-53. PMID 20378845 DOI: 10.1161/Atvbaha.110.206433  0.314
2010 Belcher JD, Vineyard JV, Bruzzone CM, Chen C, Beckman JD, Nguyen J, Steer CJ, Vercellotti GM. Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. Journal of Molecular Medicine (Berlin, Germany). 88: 665-75. PMID 20306336 DOI: 10.1007/S00109-010-0613-6  0.741
2010 Juncos JP, Grande JP, Croatt AJ, Hebbel RP, Vercellotti GM, Katusic ZS, Nath KA. Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease. American Journal of Physiology. Renal Physiology. 298: F892-9. PMID 20107113 DOI: 10.1152/Ajprenal.00631.2009  0.375
2010 Hebbel RP, Vercellotti GM, Pace BS, Solovey AN, Kollander R, Abanonu CF, Nguyen J, Vineyard JV, Belcher JD, Abdulla F, Osifuye S, Eaton JW, Kelm RJ, Slungaard A. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. Blood. 115: 2483-90. PMID 20053759 DOI: 10.1182/Blood-2009-02-204990  0.434
2010 Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. Heme degradation and vascular injury. Antioxidants & Redox Signaling. 12: 233-48. PMID 19697995 DOI: 10.1089/Ars.2009.2822  0.705
2010 Vercellotti GM, Belcher JD. Heme and the Vasculature: How the Endothelium Protects Itself Against Toxic Iron Blood. 116: SCI-25-SCI-25. DOI: 10.1182/Blood.V116.21.Sci-25.Sci-25  0.457
2010 Beckman JD, Marker PH, Nguyen J, Belcher JD, Hebbel RP, Croatt AJ, Nath KA, Vercellotti GM. Carbon Monoxide Therapy Reduces Reactive Oxygen Species Production and the Short-Term Hematopoietic Stem Cell Population In Heme-Oxygenase-1 Knockout Mice Blood. 116: 4767-4767. DOI: 10.1182/Blood.V116.21.4767.4767  0.73
2010 Romee R, Weisdorf DJ, Brunstein C, Wagner JE, Blazar BR, Majhail NS, Vercellotti GM, Miller JS, Arora M. ABO Mismatch Adversely Affects GvHD In Recipients of HLA Matched Unrelated Marrow or Peripheral Blood but Not Single or Double Umbilical Cord Blood Transplants Blood. 116: 226-226. DOI: 10.1182/Blood.V116.21.226.226  0.306
2010 Belcher JD, Nguyen J, Furne J, Vineyard J, Beckman JD, Marker PH, Hebbel RP, Levitt MD, Vercellotti GM. Exhaled Carbon Monoxide as a Marker of Hemolysis In Transgenic Mouse Models of Sickle Cell Anemia. Blood. 116: 1642-1642. DOI: 10.1182/Blood.V116.21.1642.1642  0.733
2010 Wasiluk KR, Goldish D, Benson BA, Vercellotti G, Dalmasso AP. IL-4 induces up-regulation of the junction protein claudin-5 in vascular endothelial cells, which is required for protection from killing by the membrane attack complex Molecular Immunology. 47: 2226-2226. DOI: 10.1016/J.Molimm.2010.05.091  0.304
2009 Hebbel RP, Vercellotti G, Nath KA. A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. Cardiovascular & Hematological Disorders Drug Targets. 9: 271-92. PMID 19751187 DOI: 10.2174/1871529X10909040271  0.34
2009 Beckman JD, Belcher JD, Vineyard JV, Chen C, Nguyen J, Nwaneri MO, O'Sullivan MG, Gulbahce E, Hebbel RP, Vercellotti GM. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1243-53. PMID 19617415 DOI: 10.1152/Ajpheart.00327.2009  0.74
2009 Jeney V, Komódi E, Nagy E, Zarjou A, Vercellotti GM, Eaton JW, Balla G, Balla J. Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S). Free Radical Biology & Medicine. 46: 616-23. PMID 19100829 DOI: 10.1016/J.Freeradbiomed.2008.11.018  0.312
2009 Hebbel RP, Vercellotti GM, Pace B, Solovey A, Kollander R, Abanonu C, Nguyen J, Vineyard JV, Belcher JD, Abdulla F, Osifuye S, Eaton JW, Kelm R, Slungaard A. The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease. Blood. 114: 2586-2586. DOI: 10.1182/Blood.V114.22.2586.2586  0.377
2009 Belcher BD, Vineyard JV, Bruzzone CM, Chen C, Beckman JD, Ngyuen J, Steer CJ, Vercellotti GM. Heme Oxygenase-1 Gene Therapy in a Murine Model of Sickle Cell Disease. Blood. 114: 1527-1527. DOI: 10.1182/Blood.V114.22.1527.1527  0.73
2009 Wegiel B, Bjartell A, Harris C, Belcher J, Vercellotti G, Gallo D, Csizmadia E, Helczynski L, Persson JL, Otterbein LE. Abstract C41: Heme oxygenase‐1 and carbon monoxide modulate responses to DNA damage in prostate cancer Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-C41  0.335
2008 Bruzzone CM, Belcher JD, Schuld NJ, Newman KA, Vineyard J, Nguyen J, Chen C, Beckman JD, Steer CJ, Vercellotti GM. Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy. Translational Research : the Journal of Laboratory and Clinical Medicine. 152: 290-7. PMID 19059164 DOI: 10.1016/J.Trsl.2008.10.005  0.685
2008 Wudhikarn K, Vercellotti GM, Arora M. Hypocalcemia during Autologous Stem Cell Transplant with Concurrent Biphosphonate Use in Patients with Multiple Myeloma Blood. 112: 4335-4335. DOI: 10.1182/Blood.V112.11.4335.4335  0.307
2008 Yang C, Beckman JD, Schmidt TE, Nguyen J, Belcher JD, Vercellotti GM. Potential Role of Heme Oxygenase-1 in Arsenic Trioxide and Hemin-Mediated Differentiation of Human Promyelocytic Leukemia Cells Blood. 112: 3981-3981. DOI: 10.1182/Blood.V112.11.3981.3981  0.71
2008 Beckman JD, Vineyard JV, Chen C, Ngyuen J, Nwaneri MO, Marker P, Belcher JD, Vercellotti GM. Carbon Monoxide Decreases Leukocytosis in Murine Sickle Cell Disease Models Via Decreased Granulopoiesis. Blood. 112: 1433-1433. DOI: 10.1182/Blood.V112.11.1433.1433  0.737
2008 Pasrija T, Mahmud SA, Belcher JD, Vercellotti GM, Slungaard A. Gene-Specific Effects of the Histone Deacetylase Inhibitor TSA on Activation of a Pro-Inflammatory Endothelial Cell Phenotype by the Major Phagocyte Peroxidase-Derived Oxidant HOSCN. Blood. 112: 1274-1274. DOI: 10.1182/Blood.V112.11.1274.1274  0.379
2007 Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, Balla G. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxidants & Redox Signaling. 9: 2119-37. PMID 17767398 DOI: 10.1089/Ars.2007.1787  0.371
2007 Mahmud SA, Wang J, Wei P, Thomas MS, Belcher JD, Vercellotti GM, Slungaard A. The Major Phagocyte Peroxidase-Derived Oxidant, HOSCN (Hypothiocyanous Acid), Induces Proinflammatory and Cytoprotective Gene Expression in Endothelium: A Mechanism for Microlocalized Regulation of Inflammation. Blood. 110: 3295-3295. DOI: 10.1182/Blood.V110.11.3295.3295  0.401
2007 Beckman JD, Vineyard JV, Yang C, Schmidt TE, Belcher JD, Vercellotti GM. Inhaled Carbon Monoxide: An Anti-Inflammatory Modulator in Transgenic Sickle Mice. Blood. 110: 2268-2268. DOI: 10.1182/Blood.V110.11.2268.2268  0.734
2007 Bruzzone CM, Newman KA, Belcher JD, Steer CJ, Vercellotti GM. Differentiation of Highly Conserved Host and Transgene mRNA in HO-1 Gene Therapy. Blood. 110: 2266-2266. DOI: 10.1182/Blood.V110.11.2266.2266  0.316
2006 Kaul DK, Kollander R, Mahaseth H, Liu XD, Solovey A, Belcher J, Kelm RJ, Vercellotti GM, Hebbel RP. Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation. Microcirculation (New York, N.Y. : 1994). 13: 489-97. PMID 16864415 DOI: 10.1080/10739680600778456  0.366
2006 Wang J, Shen YH, Utama B, LeMaire SA, Coselli JS, Vercellotti GM, Wang XL. HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis - involvement of ERK pathway Febs Letters. 580: 2779-2787. PMID 16650413 DOI: 10.1016/J.Febslet.2006.04.041  0.343
2006 Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. The Journal of Clinical Investigation. 116: 808-16. PMID 16485041 DOI: 10.1172/Jci26857  0.425
2006 Ujhelyi L, Balla G, Jeney V, Varga Z, Nagy E, Vercellotti GM, Agarwal A, Eaton JW, Balla J. Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions Kidney International. 69: 144-151. PMID 16374435 DOI: 10.1038/Sj.Ki.5000007  0.366
2006 Ujhelyi L, Balla G, Jeney V, Varga Z, Nagy E, Vercellotti GM, Agarwal A, Eaton JW, Balla J. Response to p-Cresol for better or worse: But what are we measuring? [5] Kidney International. 70: 232-233. DOI: 10.1038/Sj.Ki.5001531  0.322
2005 Nagy E, Jeney V, Yachie A, Szabó RP, Wagner O, Vercellotti GM, Eaton JW, Balla G, Balla J. Oxidation of hemoglobin by lipid hydroperoxide associated with low-density lipoprotein (LDL) and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 (HO-1) deficiency Cellular and Molecular Biology. 51: 377-385. PMID 16309588 DOI: 10.1170/T641  0.329
2005 Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, Balla G. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Molecular Nutrition & Food Research. 49: 1030-43. PMID 16208635 DOI: 10.1002/Mnfr.200500076  0.391
2005 Mahaseth H, Vercellotti GM, Welch TE, Bowlin PR, Sonbol KM, Hsia CJ, Li M, Bischof JC, Hebbel RP, Belcher JD. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. The Journal of Laboratory and Clinical Medicine. 145: 204-11. PMID 15962839 DOI: 10.1016/J.Lab.2005.02.008  0.432
2005 Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, Kalambur VS, Bowlin PR, Bischof JC, Hebbel RP, Vercellotti GM. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. American Journal of Physiology. Heart and Circulatory Physiology. 288: H2715-25. PMID 15665055 DOI: 10.1152/Ajpheart.00986.2004  0.459
2005 Belcher JD, Mahaseth H, Welch TE, Boakye-Agyeman F, Hebbel RP, Vercellotti GM. Oxidative Stress and Vaso-Occlusion in Sickle Cell Disease: Role of Activated Leukocytes and Redox Active Iron. Blood. 106: 3165-3165. DOI: 10.1182/Blood.V106.11.3165.3165  0.465
2004 Kalambur VS, Mahaseth H, Bischof JC, Kielbik MC, Welch TE, Vilbäck A, Swanlund DJ, Hebbel RP, Belcher JD, Vercellotti GM. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. American Journal of Hematology. 77: 117-25. PMID 15389823 DOI: 10.1002/Ajh.20143  0.399
2004 Shen YH, Utama B, Wang J, Raveendran M, Senthil D, Waldman WJ, Belcher JD, Vercellotti G, Martin D, Mitchelle BM, Wang XL. Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circulation Research. 94: 1310-7. PMID 15105295 DOI: 10.1161/01.Res.0000129180.13992.43  0.336
2004 Kaul DK, Liu XD, Choong S, Belcher JD, Vercellotti GM, Hebbel RP. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. American Journal of Physiology. Heart and Circulatory Physiology. 287: H293-301. PMID 15001449 DOI: 10.1152/Ajpheart.01150.2003  0.446
2004 Mahaseth H, Belcher JD, Welch TE, Sonbol KM, Bowlin PR, Hebbel RP, Ma L, Hsia CJ, Vercellotti GM. Polynitroxyl Albumin Prevents Vaso-Occlusion in Transgenic Sickle Mice. Blood. 104: 366-366. DOI: 10.1182/Blood.V104.11.366.366  0.465
2004 Belcher JD, Welch TE, Mahaseth H, Sonbol KM, Bowlin PR, Bischof JC, Hebbel RP, Vercellotti GM. Heme Oxygenase-1: A Potential Modulator of Inflammation and Vaso-Occlusion in Sickle Cell Disease. Blood. 104: 365-365. DOI: 10.1182/Blood.V104.11.365.365  0.48
2003 Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 18: v8-12. PMID 12817058 DOI: 10.1093/Ndt/Gfg1034  0.391
2003 Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, Vercellotti GM. Transgenic sickle mice have vascular inflammation. Blood. 101: 3953-9. PMID 12543857 DOI: 10.1182/Blood-2002-10-3313  0.429
2003 Vercellotti GM. PlGF: a link between inflammation and angiogenesis in sickle disease Blood. 102: 1153-1153. DOI: 10.1182/Blood-2003-06-1860  0.394
2002 Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 100: 879-87. PMID 12130498 DOI: 10.1182/Blood.V100.3.879  0.362
2001 Vercellotti GM. Overview of infections and cardiovascular diseases Journal of Allergy and Clinical Immunology. 108: S117-S120. PMID 11586278 DOI: 10.1067/Mai.2001.117976  0.322
2001 Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants Journal of Immunology. 166: 4185-4194. PMID 11238670 DOI: 10.4049/Jimmunol.166.6.4185  0.348
2001 Nath KA, Vercellotti GM, Grande JP, Miyoshi H, Paya CV, Manivel JC, Haggard JJ, Croatt AJ, Payne WD, Alam J. Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1 Kidney International. 59: 106-117. PMID 11135063 DOI: 10.1046/J.1523-1755.2001.00471.X  0.411
2000 Wang J, Marker PH, Belcher JD, Wilcken DEL, Burns LJ, Vercellotti GM, Wang XL. Human cytomegalovirus immediate early proteins upregulate endothelial p53 function Febs Letters. 474: 213-216. PMID 10838087 DOI: 10.1016/S0014-5793(00)01604-5  0.334
2000 Bratt J, Belcher J, Vercellotti GM, Palmblad J. Effects of anti-rheumatic gold salts on NF-κB mobilization and tumour necrosis factor-alpha (TNF-α)-induced neutrophil-dependent cytotoxicity for human endothelial cells Clinical and Experimental Immunology. 120: 79-84. PMID 10759767 DOI: 10.1046/J.1365-2249.2000.01190.X  0.334
2000 Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion Blood. 96: 2451-2459. DOI: 10.1182/Blood.V96.7.2451.H8002451_2451_2459  0.409
2000 Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice Blood. 96: 314-320. DOI: 10.1182/Blood.V96.1.314  0.387
2000 Balla J, Balla G, Jeney V, Kakuk G, Jacob HS, Vercellotti GM. Ferriporphyrins and endothelium: a 2-edged sword—promotion of oxidation and induction of cytoprotectants Blood. 95: 3442-3450. DOI: 10.1182/Blood.V95.11.3442.011K51_3442_3450  0.4
1999 Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, Vercellotti GM. Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia Journal of Laboratory and Clinical Medicine. 133: 605-612. PMID 10360636 DOI: 10.1016/S0022-2143(99)90191-9  0.345
1999 Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins Transplantation. 67: 137-144. PMID 9921810 DOI: 10.1097/00007890-199901150-00023  0.341
1998 Juckett M, Zheng Y, Yuan H, Pastor T, Antholine W, Weber M, Vercellotti G. Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. The Journal of Biological Chemistry. 273: 23388-97. PMID 9722574 DOI: 10.1074/Jbc.273.36.23388  0.355
1997 Matthews AJ, Vercellotti GM, Menchaca HJ, Bloch PHS, Michalek VN, Marker PH, Murar J, Buchwald H. Iron and atherosclerosis: Inhibition by the iron chelator deferiprone (L1)1 Journal of Surgical Research. 73: 35-40. PMID 9441790 DOI: 10.1006/Jsre.1997.5180  0.313
1996 Juckett MB, Weber M, Balla J, Jacob HS, Vercellotti GM. Nitric oxide donors modulate ferritin and protect endothelium from oxidative injury Free Radical Biology and Medicine. 20: 63-73. PMID 8903680 DOI: 10.1016/0891-5849(95)02024-1  0.345
1996 Agarwal A, Balla J, Balla G, Croatt AJ, Vercellotti GM, Nath KA. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 271: F814-F823. PMID 8898011 DOI: 10.1152/Ajprenal.1996.271.4.F814  0.381
1995 Balla J, Nath KA, Balla G, Juckett MB, Jacob HS, Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo American Journal of Physiology - Lung Cellular and Molecular Physiology. 268: L321-L327. PMID 7864152 DOI: 10.1152/Ajplung.1995.268.2.L321  0.337
1995 Nath KA, Balla J, Croatt AJ, Vercellotti GM. Heme protein-mediated renal injury: A protective role for 21-aminosteroids in vitro and in vivo Kidney International. 47: 592-602. PMID 7723246 DOI: 10.1038/Ki.1995.75  0.319
1994 Vercellotti GM, Balla G, Balla J, Nath K, Eaton JW, Jacob HS. Heme and the vasculature: An oxidative hazard that induces antioxidant defenses in the endothelium Artificial Cells, Blood Substitutes, and Biotechnology. 22: 207-213. PMID 8087243 DOI: 10.3109/10731199409117415  0.353
1993 Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage Proceedings of the National Academy of Sciences of the United States of America. 90: 9285-9289. PMID 8415693 DOI: 10.1073/Pnas.90.20.9285  0.395
1993 Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil cationic granule proteins impair thrombomodulin function: A potential mechanism for thromboembolism in hypereosinophilic heart disease Journal of Clinical Investigation. 91: 1721-1730. PMID 8386194 DOI: 10.1172/Jci116382  0.309
1993 Belcher JD, Balla J, Balla G, Jacobs DR, Gross M, Jacob HS, Vercellotti GM. Vitamin E, LDL, and endothelium: Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro Arteriosclerosis, Thrombosis, and Vascular Biology. 13: 1779-1789. PMID 8241098 DOI: 10.1161/01.Atv.13.12.1779  0.318
1993 Cermak J, Key N, Bach R, Balla J, Jacob H, Vercellotti G. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor Blood. 82: 513-520. DOI: 10.1182/Blood.V82.2.513.513  0.36
1993 Bok RA, Jacob HS, Balla J, Juckett M, Stelle T, Shatos MA, Vercellotti GM. Herpes Simplex Virus Decreases Endothelial Cell Plasminogen Activator Inhibitor Thrombosis and Haemostasis. 69: 253-258. DOI: 10.1055/S-0038-1651590  0.317
1993 Eaton J, Balla G, Balla J, Vercellotti G. Heme iron and oxidative cell death Free Radical Biology and Medicine. 15: 516. DOI: 10.1016/0891-5849(93)90354-W  0.313
1992 Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levin MD, Rosenberg ME. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat Journal of Clinical Investigation. 90: 267-270. PMID 1634613 DOI: 10.1172/Jci115847  0.321
1992 Key NS, Platt JL, Vercellotti GM. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils Arteriosclerosis, Thrombosis, and Vascular Biology. 12: 836-842. PMID 1616909 DOI: 10.1161/01.Atv.12.7.836  0.396
1992 Antonov AS, Key NS, Smirnov MD, Jacob HS, Vercellotti GM, Smirnov VN. Prothrombotic phenotype diversity of human aortic endothelial cells in culture Thrombosis Research. 67: 135-145. PMID 1332214 DOI: 10.1016/0049-3848(92)90133-U  0.335
1992 Stroncek D, Vercellotti G, Hammerschmidt D, Christie D, Shankar R, Jacob H. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis Blood. 80: 241-248. DOI: 10.1182/Blood.V80.1.241.Bloodjournal801241  0.304
1991 Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury Arteriosclerosis, Thrombosis, and Vascular Biology. 11: 1700-1711. PMID 1931871 DOI: 10.1161/01.Atv.11.6.1700  0.322
1991 Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: Potential for prevention of xenograft hyperacute rejection Transplantation. 52: 530-533. PMID 1716798 DOI: 10.1097/00007890-199109000-00029  0.357
1991 Lee PK, Vercellotti GM, Deringer JR, Schlievert PM. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells Journal of Infectious Diseases. 164: 711-719. PMID 1654356 DOI: 10.1093/Infdis/164.4.711  0.31
1990 Key NS, Vercellotti GM, Winkelmann JC, Moldow CF, Goodman JL, Esmon NL, Esmon CT, Jacob HS. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proceedings of the National Academy of Sciences of the United States of America. 87: 7095-9. PMID 2169619 DOI: 10.1073/Pnas.87.18.7095  0.309
1990 Confer DL, Vercellotti GM, Kotasek D, Goodman JL, Ochoa A, Jacob HS. Herpes simplex virus-infected cells disarm killer lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 87: 3609-13. PMID 2159156 DOI: 10.1073/Pnas.87.9.3609  0.303
1990 Platt JL, Vercellotti GM, Lindman BJ, Oegema TR, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells - Implications for pathogenesis of hyperacute rejection Journal of Experimental Medicine. 171: 1363-1368. PMID 2139104 DOI: 10.1084/Jem.171.4.1363  0.386
1990 Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS. Tumor necrosis factor α/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium Journal of Experimental Medicine. 171: 2025-2041. PMID 1972179 DOI: 10.1084/Jem.171.6.2025  0.373
1989 Vercellotti GM, Wickham NWR, Gustafson KS, Yin HQ, Hebert M, Jacob HS. Thrombin-treated endothelium primes neutrophil functions: Inhibition by platelet-activating factor receptor antagonists Journal of Leukocyte Biology. 45: 483-490. PMID 2542422 DOI: 10.1002/Jlb.45.6.483  0.369
1988 Farber NE, Vercellotti GM, Jacob HS, Pieper GM, Gross GJ. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart Circulation Research. 63: 351-360. PMID 3396156 DOI: 10.1161/01.Res.63.2.351  0.311
1988 Vercellotti GM, Dobson M, Schorer AE, Moldow CF. Endothelial Cell Heterogeneity: Antioxidant Profiles Determine Vulnerability to Oxidant Injury Proceedings of the Society For Experimental Biology and Medicine. 187: 181-189. PMID 3340627 DOI: 10.3181/00379727-187-42652  0.361
1988 Visser MR, Tracy PB, Vercellotti GM, Goodman JL, White JG, Jacob HS. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proceedings of the National Academy of Sciences of the United States of America. 85: 8227-30. PMID 2847155 DOI: 10.1073/Pnas.85.21.8227  0.32
1988 Vercellotti G, Yin H, Gustafson K, Nelson R, Jacob H. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage Blood. 71: 1100-1107. DOI: 10.1182/Blood.V71.4.1100.Bloodjournal7141100  0.358
1987 Smith CM, Hebbel RP, Tukey DP, Clawson CC, White JG, Vercellotti GM. Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. Blood. 69: 1631-1636. DOI: 10.1182/Blood.V69.6.1631.1631  0.351
1987 Jacob H, Wickham N, Vercellotti G. PAF as a facilitator of the immune response: Its role in priming inflammatory and endothelial cells Prostaglandins. 34: 171. DOI: 10.1016/0090-6980(87)90214-0  0.319
1986 Stroncek DF, Vercellotti GM, Pil Won Huh, Jacob HS. Neutrophil oxidants inactivate alpha-1-protease inhibitor and promote PMN-mediated detachment of cultured endothelium. Protection by free methionine Arteriosclerosis. 6: 332-340. PMID 3486653 DOI: 10.1161/01.Atv.6.3.332  0.376
1985 Vercellotti GM, Van Asbeck BS, Jacob HS. Oxygen radical-induced erythrocyte hemolysis by neutrophils. Critical role of iron and lactoferrin Journal of Clinical Investigation. 76: 956-962. PMID 2995452 DOI: 10.1172/Jci112095  0.32
1985 Van Asbeck BS, Hoidal J, Vercellotti GM, Schwartz BA, Moldow CF, Jacob HS. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: Role of red cell glutathione Science. 227: 756-759. PMID 2982213 DOI: 10.1126/Science.2982213  0.334
1985 Perri RT, Vercellotti G, McCarthy J, Vessella RL, Furcht LT. Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity. Journal of Laboratory and Clinical Medicine. 105: 30-35. DOI: 10.5555/Uri:Pii:002221438590085X  0.313
1984 Ascensao JL, Vercellotti GM, Jacob HS, Zanjani ED. Role of endothelial cells in human hematopoiesis: Modulation of mixed colony growth in vitro Blood. 63: 553-558. PMID 6607755 DOI: 10.1182/Blood.V63.3.553.553  0.345
1983 Vercellotti G, McCarthy J, Furcht L, Jacob H, Moldow C. Inflamed fibronectin: an altered fibronectin enhances neutrophil adhesion Blood. 62: 1063-1069. DOI: 10.1182/Blood.V62.5.1063.Bloodjournal6251063  0.378
1982 Jacob HS, Moldow CF, Flynn PJ, Weisdorf DJ, Vercellotti GM, Hammerschmidt DE. Therapeutic ramifications of the interaction of complement, granulocytes, and platelets in the production of acute lung injury. Annals of the New York Academy of Sciences. 384: 489-95. PMID 6953835 DOI: 10.1111/J.1749-6632.1982.Tb21395.X  0.34
Show low-probability matches.